Carotenoids, retinol, tocopherols, and prostate cancer risk: Pooled analysis of 15 studies

American Journal of Clinical Nutrition

Volumn 102, Issue 5, 2015, Pages 1142-1157

  Key, Timothy J ^a   Appleby, Paul N ^a   Travis, Ruth C ^a   Albanes, Demetrius ^b   Alberg, Anthony J ^c,d   Barricarte, Aurelio ^e,f   Black, Amanda ^b   Boeing, Heiner ^g   Bueno De Mesquita, H Bas ^h,i,j   Chan, June M ^k   Chen, Chu ^l   Cook, Michael B ^b   Donovan, Jenny L ^m   Galan, Pilar ⁿ   Gilbert, Rebecca ^m   Giles, Graham G ^o   Giovannucci, Edward ^p,q   Goodman, Gary E ^r   Goodman, Phyllis J ^l   Gunter, Marc J ^j   Hamdy, Freddie C ^a   Heliövaara, Markku ^s   Helzlsouer, Kathy J ^t   Henderson, Brian E ^u   Hercberg, Serge ⁿ   Hoffman Bolton, Judy ^v   Hoover, Robert N ^b   Johansson, Mattias ^w,x,y   Khaw, Kay Tee ^z   King, Irena B ^l,ah   Knekt, Paul ^s   Kolonel, Laurence N ^aa   Le Marchand, Loic ^aa   Männistö, Satu ^s   Martin, Richard M ^m,ab,ac   Meyer, Haakon E ^ad   Mondul, Alison M ^b   Moy, Kristin A ^b   Neal, David E ^z   Neuhouser, Marian L ^l   Palli, Domenico ^ae   Platz, Elizabeth A ^c   Pouchieu, Camille ^o   Rissanen, Harri ^s   Schenk, Jeannette M ^l   Severi, Gianluca ^m   Stampfer, Meir J ^p,q   Tjønneland, Anne ^af   Touvier, Mathilde ⁿ   Trichopoulou, Antonia ^ag   Weinstein, Stephanie J ^b   Ziegler, Regina G ^b   Zhou, Cindy Ke ^b   Allen, Naomi E ^a   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^h NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

ⁱ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l Fred Hutchinson Cancer Research Center   (United States)

^m UNIVERSITY OF BRISTOL   (United Kingdom)

ⁿ UNIVERSITÉ PARIS 13   (France)

^o CANCER EPIDEMIOLOGY CENTRE   (Australia)

^p HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^q BRIGHAM AND WOMEN S HOSPITAL   (United States)

^r UNIVERSITY OF WASHINGTON   (United States)

^s NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^t MERCY MEDICAL CENTER   (United States)

^u UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^v George W Comstock Center for Public Health Research   (United States)

^w INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^x UMEÅ UNIVERSITY   (Sweden)

^y UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^z UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^aa UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^ab UNIVERSITY OF BRISTOL   (United Kingdom)

^ac The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

^ad UNIVERSITY OF OSLO   (Norway)

^ae CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^af INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^ag HELLENIC HEALTH FOUNDATION   (Greece)

^ah UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Biomarkers; Carotenoids; Nested case control study; Pooled analysis; Prostate cancer; Retinol; Tocopherols; Vitamin A; Vitamin E

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; CAROTENOID; GAMMA TOCOPHEROL; RETINOL; BIOLOGICAL MARKER; LYCOPENE;

ADULT; AGED; ANALYSIS; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; POOLED ANALYSIS; PROSTATE CANCER; SMOKING; VITAMIN BLOOD LEVEL; BLOOD; CANCER GRADING; CANCER STAGING; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; META ANALYSIS (TOPIC); MIDDLE AGED; OBSERVATIONAL STUDY; PATHOLOGY; PROSPECTIVE STUDY; PROSTATE; PROSTATIC NEOPLASMS; RISK FACTOR;

ADULT; ALPHA-TOCOPHEROL; BIOMARKERS; CAROTENOIDS; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; OBSERVATIONAL STUDIES AS TOPIC; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; RISK FACTORS; VITAMIN A;

EID: 84946057411     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.114306     Document Type: Article

References (52)

1. Chan JM, Gann PH, Giovannucci EL. Role of diet in prostate cancer development and progression. J Clin Oncol 2005;23:8152-60.
2. Krinsky NI, Johnson EJ. Carotenoid actions and their relation to health and disease. Mol Aspects Med 2005;26:459-516.
3. O'Neill ME, Carroll Y, Corridan B, Olmedilla B, Granado F, Blanco I, Van den Berg H, Hininger I, Rousell AM, Chopra M, et al. A European carotenoid database to assess carotenoid intakes and its use in a fivecountry comparative study. Br J Nutr 2001;85:499-507.
4. Schlatterer J, Breithaupt DE. Xanthophylls in commercial egg yolks: quantification and identification by HPLC and LC-(APCI)MS using a C30 phase. J Agric Food Chem 2006;54:2267-73.
5. McKevith B. Is salmon salmon pink? The use of canthaxanthin in animal feeds. Nutr Bull 2003;28:243-5.
6. Ford ES, Schleicher RL, Mokdad AH, Ajani UA, Liu S. Distribution of serum concentrations of alpha-tocopherol and gamma-tocopherol in the US population. Am J Clin Nutr 2006;84:375-83.
7. Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, et al. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 2008;149:461-71, W83-88.
8. Roddam AW, Allen NE, Appleby P, Key TJ; Endogenous Hormones and Prostate Cancer Collaborative Group. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 2008;100:170-83.
9. Crowe FL, Appleby PN, Travis RC, Barnett M, Brasky TM, Bueno-de-Mesquita HB, Chajes V, Chavarro JE, Chirlaque MD, English DR, et al. Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies. J Natl Cancer Inst 2014;106:dju240.
10. Giovannucci E. Commentary: Serum lycopene and prostate cancer progression: a re-consideration of findings from the prostate cancer prevention trial. Cancer Causes Control 2011;22:1055-9.
11. Mondul AM, Watters JL, Männistö S,Weinstein SJ, Snyder K, Virtamo J, Albanes D. Serum retinol and risk of prostate cancer. Am J Epidemiol 2011;173:813-21.
12. Mondul AM, Rohrmann S, Menke A, Feinleib M, Nelson WG, Platz EA, Albanes D. Association of serum a-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk. Cancer Causes Control 2011;22:827-36.
13. Hartman TJ, Albanes D, Pietinen P, Hartman AM, RautalahtiM, Tangrea JA, Taylor PR. The association between baseline Vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev 1998;7:335-40.
14. Weinstein SJ, Wright ME, Lawson KA, Snyder K, Männistö S, Taylor PR, Virtamo J, Albanes D. Serum and dietary Vitamin E in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007;16:1253-9.
15. Goodman GE, Schaffer S, Omenn GS, Chen C, King I. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev 2003;12:518-26.
16. Hsing AW, Comstock GW, Abbey H, Polk BF. Serologic precursors of cancer: retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 1990;82:941-6.
17. Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol 2003;157:335-44.
18. Key TJ, Appleby PN, Allen NE, Travis RC, Roddam AW, Jenab M, Egevad L, Tjønneland A, Johnsen NF, Overvad K, et al. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr 2007;86:672-81.
19. Knekt P, Aromaa A, Maatela J, Aaran RK, Nikkari T, Hakama M, Hakulinen T, Peto R, Teppo L. Serum Vitamin A and subsequent risk of cancer: cancer incidence follow-up of the Finnish Mobile Clinic Health Examination Survey. Am J Epidemiol 1990;132:857-70.
20. Wu K, Erdman JW Jr., Schwartz SJ, Platz EA, Leitzmann M, Clinton SK, DeGroff V, Willett WC, Giovannucci E. Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2004;13:260-9.
21. Meyer HE, Robsahm TE, Bjørge T, Brustad M, Blomhoff R. Vitamin D, season and risk of prostate cancer: a nested case-control study within Norwegian health studies. Am J Clin Nutr 2013;97:147-54.
22. Hodge AM, Simpson JA, Fridman M, Rowley K, English DR, Giles GG, Su Q, O'Dea K. Evaluation of an FFQ for assessment of antioxidant intake using plasma biomarkers in an ethnically diverse population. Public Health Nutr 2009;12:2438-47.
23. Bassett JK, Severi G, Hodge AM, MacInnis RJ, Gibson RA, Hopper JL, English DR, Giles GG. Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk. Int J Cancer 2013;133:1882-91.
24. Gill JK, Franke AA, Steven Morris J, Cooney RV, Wilkens LR, Le Marchand L, Goodman MT, Henderson BE, Kolonel LN. Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort. Cancer Causes Control 2009;20:1161-71.
25. Kristal AR, Till C, Platz EA, Song X, King IB, Neuhouser ML, Ambrosone CB, Thompson IM. Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev 2011;20:638-46.
26. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999;59: 1225-30.
27. Schenk JM, Riboli E, Chatterjee N, Leitzmann MF, Ahn J, Albanes D, Reding DJ, Wang Y, Friesen MD, Hayes RB, et al. Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2009;18:1227-31.
28. Peters U, Leitzmann MF, Chatterjee N, Wang Y, Albanes D, Gelmann EP, Friesen MD, Riboli E, Hayes RB. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2007;16:962-8.
29. Weinstein SJ, Peters U, Ahn J, Friesen MD, Riboli E, Hayes RB, Albanes D. Serum a-tocopherol and g-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study. PLoS One 2012;7:e40204.
30. Gilbert R, Metcalfe C, Fraser WD, Donovan J, Hamdy F, Neal DE, Lane JA, Martin RM. Associations of circulating retinol, Vitamin E, and 1,25-dihydroxyVitamin D with prostate cancer diagnosis, stage, and grade. Cancer Causes Control 2012;23:1865-73.
31. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briancon S. The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004;164:2335-42.
32. Finne P, Fallah M, Hakama M, Ciatto S, Hugosson J, de Koning H, Moss S, Nelen V, Auvinen A. Lead-time in the European Randomised Study of Screening for Prostate Cancer. Eur J Cancer 2010;46: 3102-8.
33. Nomura AM, Stemmermann GN, Lee J, Craft NE. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 1997;6:487-91.
34. Reichman ME, Hayes RB, Ziegler RG, Schatzkin A, Taylor PR, Kahle LL, Fraumeni JF Jr. Serum Vitamin A and subsequent development of prostate cancer in the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Cancer Res 1990;50:2311-5.
35. Beilby J, Ambrosini GL, Rossi E, de Klerk NH, Musk AW. Serum levels of folate, lycopene, b-carotene, retinol and Vitamin E and prostate cancer risk. Eur J Clin Nutr 2010;64:1235-8.
36. Karppi J, Kurl S, Nurmi T, Rissanen TH, Pukkala E, Nyyssönen K. Serum lycopene and the risk of cancer: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) study. Ann Epidemiol 2009;19:512-8.
37. Karppi J, Kurl S, Laukkanen JA, Kauhanen J. Serum b-carotene in relation to risk of prostate cancer: the Kuopio Ischaemic Heart Disease Risk Factor study. Nutr Cancer 2012;64:361-7.
38. Eichholzer M, Stähelin HB, Lü din E, Bernasconi F. Smoking, plasma vitamins C, E, retinol, and carotene, and fatal prostate cancer: seventeen-year follow-up of the prospective Basel study. Prostate 1999;38:189-98.
39. Engeland A, Tretli S, Bjørge T. Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. Br J Cancer 2003;89: 1237-42.
40. Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, Tjønneland A, Johnsen NF, Overvad K, Linseisen J, Rohrmann S, et al. Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 2008;98: 1574-81.
41. Rohrmann S, Linseisen J, Allen N, Bueno-de-Mesquita HB, Johnsen NF, Tjønneland A, Overvad K, Kaaks R, Teucher B, Boeing H, et al. Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 2013;108:708-14.
42. Khillan JS. Vitamin a/retinol and maintenance of pluripotency of stem cells. Nutrients 2014;6:1209-22.
43. Rohde CM, DeLuca HF. All-trans retinoic acid antagonizes the action of calciferol and its active metabolite, 1,25-dihydroxycholecalciferol, in rats. J Nutr 2005;135:1647-52.
44. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, Haapakoski J, Malila N, Rautalahti M, Ripatti S, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998; 90:440-6.
45. Gaziano JM, Glynn RJ, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Sesso HD, Buring JE. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 2009;301:52-62.
46. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:23-33.
47. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, et al. Effects of long-term Vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005;293:1338-47.
48. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, et al. Effect of selenium and Vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301:39-51.
49. Klein EA, Thompson IM Jr., Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011;306:1549-56.
50. Key TJ, Appleby PN, Allen NE, Reeves GK. Pooling biomarker data from different studies of disease risk, with a focus on endogenous hormones. Cancer Epidemiol Biomarkers Prev 2010;19:960-5.
51. Eliassen AH, Hendrickson SJ, Brinton LA, Buring JE, Campos H, Dai Q, Dorgan JF, Franke AA, Gao YT, Goodman MT, et al. Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl Cancer Inst 2012;104:1905-16.
52. Comstock GW, Burke AE, Hoffman SC, Norkus EP, Gross M, Helzlsouer KJ. The repeatability of serum carotenoid, retinoid, and tocopherol concentrations in specimens of blood collected 15 years apart. Cancer Epidemiol Biomarkers Prev 2001;10:65-8.